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To Use or Not to Use Heparin during Abdominal Aortic Aneurysm Repair?
F. Biancari*
Department of Surgery, Oulu University Hospital, Kajaanintie 50, PL 21, 90029 Oulu, FinlandAfter its discovery by McLead1 in 1916, heparin was ﬁrst used in
the 1950s and since then has remained the standard anticoagulant
to avoid the risk of intraoperative arterial and venous thrombo-
embolism in cardiovascular surgery. Its use is not without risks,
bleeding being the most frequent and severe complication. This is
particularly true during major vascular surgery such as open repair
of abdominal aortic aneurysm (AAA). However, since thrombo-
embolismmay pose the vascular reconstruction and patient’s life at
risk, currently most of surgeons routinely administer heparin
intravenously during elective open and endovascular repair of
AAA.2 In this issue of the Journal, Wiersema et al.3 reported the
results of a systematic review on this issue claiming that intra-
operative use of heparinmay not be beneﬁcial during repair of AAA.
Such conclusions do not apply to repair of ruptured AAA or endo-
vascular treatment because data on these are scarce. The authors
did not perform a meta-analysis, but a personal analysis of data on
elective open repair of AAA revealed a risk ratio for mortality of
0.984 (95% conﬁdence interval (CI) 0.368e2.629, three studies
included), for arterial thromboembolism of 0.966 (95%CI
0.496e1.881, four studies included) and for myocardial infarction of
1.198 (95%CI 0.032e44.414, two studies included). These data
indicate that intravenous administration of heparin may not
provide any beneﬁt to patients undergoing elective open repair of
AAA. However, such results should be viewed in the light of
a limited number of studies of small size and suboptimal quality. In
particular, selection bias is a major problem with these studies.
Furthermore, patients not receiving intravenous heparin may have
received a signiﬁcant amount of diluted heparin in saline in the
graft and iliac or femoral arteries, namely uncontrolledDOI of original article: 10.1016/j.ejvs.2012.06.008.
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ischaemic colitis5 and spinal cord ischaemia6 in patients not hep-
arinised. Similarly, lack of heparinisation may expose patients with
coronary artery disease to an increased risk of cardiac events.7 I
believe that intravenous heparinisation was a major achievement
in the early years of vascular surgery. In an era of aggressive
antithrombotic treatments, it would be difﬁcult to safely prove the
non-inferiority or even superiority of a no-heparinisation policy
during major vascular surgery.
References
1 McLean J. The thromboplastic action of cephalin. Am J Physiol 1916;41:250e7.
2 Moussa O, Jonker L, Joseph T. Marked variation in venous thromboprophylaxis
management for abdominal aortic aneurysm repair; results of survey amongst
vascular surgeons in the United kingdom. Eur J Vasc Endovasc Surg
2011;42:591e5.
3 Wiersema AM, Jongkind V, Bruijninckx CMA, Reijnen MMPJ, Vos JA, van
Delden OM, et al. Prophylactic perioperative antithrombotics in open and
endovascular abdominal aortic aneurysm (AAA) surgery: a systematic review.
Eur J Vasc Endovasc Surg 2012;44(4):359e67.
4 Samson RH, Showalter DP. A selective approach to heparin use during elective
abdominal aortic aneurysm resection: techniques, precautions, and advantages.
Ann Vasc Surg 2002;16:279e85.
5 Gloviczki P, Cross SA, Stanson AW, Carmichael SW, Bower TC, Pairolero PC, et al.
Ischemic injury to the spinal cord or lumbosacral plexus after aorto-iliac
reconstruction. Am J Surg 1991;162:131e6.
6 Johnston KW. Multicenter prospective study of nonruptured abdominal aortic
aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg
1988;9:437e47.
7 Thompson JF, Mullee MA, Bell PR, Campbell WB, Chant ADB, Darke SG, et al.
Intraoperative heparinisation, blood loss and myocardial infarction during aortic
aneurysm surgery: a joint vascular research group study. Eur J Vasc Endovasc Surg
1996;12:86e90.ed by Elsevier Ltd. All rights reserved.
